Assignee
HANDA THERAPEUTICS LLC
US·5 granted patents·0 citations·filing 2022–2024
Top patents by PatentIndex Score
5 records- 0185US12558355B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2023·Granted Feb 24, 2026·0 cites·22 claims
- 0281US12544376B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Feb 10, 2026·0 cites·19 claims
- 0381US12465606B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 0481US12433891B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Oct 7, 2025·0 cites·20 claims
- 0579US12478625B2Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and usesHANDA THERAPEUTICS LLC·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when HANDA THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →